Early disease detection enabled through the discovery of biomarkers using non-invasive breath biopsy San Jose, Calif. – Thermo Fisher Scientific, the world leader in serving science, and Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, have entered into a collaborative partnership to advance the early diagnosis […]
Lyon, France — Hitachi, Ltd. (TSE:6501, “Hitachi”) and Centre Léon Bérard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, today announced the signing of an agreement with C4 Therapeutics, Inc. to acquire an exclusive license for the Achilles-TAG (aTAG) degradation platform. The license will make aTAG technology commercially […]
As the first and only platform with these capabilities, the Tapestri Platform will enable key insights to drive the development of more impactful cancer therapies SOUTH SAN FRANCISCO, Calif. Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced its expansion into single-cell multi-omics. The company’s proprietary technology, the […]
Madison, WI USA. Promega Corporation today announced it has entered into a global collaboration with Merck, known as MSD outside the United States and Canada, to develop Promega’s microsatellite instability (MSI) technology as an on-label, solid tumor companion diagnostic (CDx) for use with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab). The global collaboration will initially seek regulatory […]
PALO ALTO, Calif. & SCHLIEREN, Switzerland– R&D services platform will make it easier for researchers throughout the world to purchase InSphero assay ready models and services for drug efficacy and safety testing Science Exchange, the world’s leading SaaS-enabled marketplace for outsourced R&D, and InSphero AG today announced a collaboration to facilitate access to InSphero’s comprehensive portfolio of […]
Collaborates with Repertoire Genesis for access to T-cell /B-cell receptor repertoire assays for clinical next-generation sequencing Acquires licensing rights for epigenomic (DNA methylation) immune checkpoint inhibitor biomarkers developed by researchers from the University of Bonn Receives exclusive license to novel mRNA gene expression signatures from STRATIFYER Molecular Pathology GmbH which may guide treatment decisions for […]
Integration of PAA’s S-LAB with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development Launch at ELRIG Drug Discovery 2019, 5–6 November, Liverpool Cambridge and Farnborough, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leading […]
In Exclusive Licensing Agreement, Company’s FlowCam® Nano Particle Imaging and Analysis System to Apply Patented AI Scarborough, ME: Global laboratory instrumentation manufacturer Fluid Imaging Technologies, Scarborough, ME (www.fluidimaging.com), and the University of Colorado have entered into an exclusive patent licensing agreement aiming for the automated detection and identification of waterborne and bloodborne bacteria, as well […]
Chemopharm Sdn Bhd, an Everlife investment and leading laboratory and medical devices distributor headquartered in Malaysia, is proud to be appointed the exclusive distributor of PAC’s Physical Properties Testing and Elemental Analysis products in Malaysia, which includes the Alcor, Antek, Herzog, ISL, PAC and Phase Technology brands. This is an extension of the successful relationship […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
